Table 3 Multivariate linear regression of change in total atheroma volume (n = 204)

Liraglutide treatment

42.8

0.13

(-13.3–99.0)

Insulin use

7.0

0.80

(-46.7–60.7)

Diabetes duration, (years)

1.6

0.48

(-3.0–6.2)

Age, (years)

0.79

0.57

(-1.9–3.56)

Hb1Ac, (mmol/mol)

0.06

0.95

(-1.8–1.9)

Lipid-lowering treatment, (years)

-1.6

0.49

(-6.2–2.9)

Triglycerides, (mmol/L)

-2.5

-0.84

(-27.0–22.0)

BMI, (kg/m²)

-3.1

0.24

(-8.5–2.2)

Sex

-32.2

0.24

(-86.2–21.7)